4-Chloro-3-nitrobenzoic acid
4-Chloro-3-nitrobenzoic acid has oral activity, and oral administration can affect the synthesis activity of liver proteins and the activities of urokinase and histidine kinase[1][2].
Product Specifications
CAS Number
96-99-1
UNSPSC
12352200
Hazard Statement
H315, H319, H335
Target
Biochemical Assay Reagents
Type
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/4-chloro-3-nitrobenzoic-acid.html
Concentration
10mM
Purity
99.52
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O=C(O)C1=CC=C(Cl)C([N+]([O-])=O)=C1
Molecular Formula
C7H4ClNO4
Molecular Weight
201.56
Precautions
H315, H319, H335
References & Citations
[1]Thompson AJ, et al. The mechanism of bending in co-crystals of caffeine and 4-chloro-3-nitrobenzoic acid. Nat Commun. 2021 Oct 20;12 (1) :5983. |[2]D'eng B, et al. Otsenka gepatotoksicheskogo deĭstviia nekotorykh khlor- nitroproizvodnykh benzoĭnoĭ kisloty [Evaluation of the hepatotoxic activity of several chlor-nitro derivatives of benzoic acid]. Vopr Med Khim. 1983 Nov-Dec;29 (6) :113-7. Russian.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740181-500 1x 500 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880253-100 1x 100 µL
Cytokeratin, LMW (AE-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040977-100 1x 100 µL
TGF-beta (1D11.16.8), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400266-100 1x 100 µL
Human IgG Immunoglobulin (IG266), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881209-500 1x 500 µL
CD45RO (UCHL1 + T200/797), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details